Cembranoid inhibitors of nicotinic acetylcholine receptors
OwnerVesna A. Eterovic, Abimael D. Rodriguez +4inventors
InventorsVesna A. Eterovic, Abimael D. Rodriguez, Richard M. Hann, Pedro A. Ferchmin, One R. Pagan, Misty J. Eaton
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of cembranoids to inhibit nicotinic acetylcholine receptors.
Claims20
A method of inhibiting at least one nicotinic acetylcholine receptor, said method comprising administering to a host in need of said inhibiting a cembranoid, wherein said at least one cembranoid is administered in an amount sufficient to achieve a concentration, within said host, of approximately 10−8 to 10−15 molar.
A method of treating a disorder involving memory loss, cognitive problems, and/or dementia, said method comprising administering to a host in need of said treating at least one cembranoid, wherein said at least one cembranoid is administered in an amount sufficient to achieve a concentration, within the host, of approximately 10−8 to 10−15 molar.
Dependencies are inferred from the claim text.